Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong

Saved in:
Bibliographic Details
Published in:Journal of Asthma and Allergy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871928243799457792
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Asthma and Allergy
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:107523
institution FRELIP
journal_source_facet Journal of Asthma and Allergy
last_indexed 2026-07-28T03:38:08.250Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_alt Agonistas del receptor del péptido similar al glucagón tipo 1 frente al uso de inhibidores de la dipeptidil peptidasa-4 sobre el riesgo de exacerbación del asma en pacientes diabéticos con asma comórbida en Hong Kong
Agonistes des récepteurs du glucagon-like peptide-1 vs inhibiteurs de la dipeptidyl peptidase-4 sur le risque d'exacerbation de l'asthme chez les patients diabétiques avec asthme comorbide à Hong Kong
Uso de Agonistas do Receptor do Peptídeo-1 Semelhante ao Glucagon vs Inibidor da Dipeptidil Peptidase-4 no Risco de Exacerbação da Asma entre Pacientes Diabéticos com Asma Comórbida em Hong Kong
title_auth Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_es_txt Agonistas del receptor del péptido similar al glucagón tipo 1 frente al uso de inhibidores de la dipeptidil peptidasa-4 sobre el riesgo de exacerbación del asma en pacientes diabéticos con asma comórbida en Hong Kong
title_fr_txt Agonistes des récepteurs du glucagon-like peptide-1 vs inhibiteurs de la dipeptidyl peptidase-4 sur le risque d'exacerbation de l'asthme chez les patients diabétiques avec asthme comorbide à Hong Kong
title_full Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_fullStr Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_full_unstemmed Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_pt_txt Uso de Agonistas do Receptor do Peptídeo-1 Semelhante ao Glucagon vs Inibidor da Dipeptidil Peptidase-4 no Risco de Exacerbação da Asma entre Pacientes Diabéticos com Asma Comórbida em Hong Kong
title_short Glucagon-Like Peptide-1 Receptor Agonists vs Dipeptidyl Peptidase-4 Inhibitor Use on Risk of Asthma Exacerbation Among Diabetic Patients with Co-Morbid Asthma in Hong Kong
title_sort glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor use on risk of asthma exacerbation among diabetic patients with co-morbid asthma in hong kong
topic Allergology and Immunology
General
Allergology and Immunology
url https://www.dovepress.com/glucagon-like-peptide-1-receptor-agonists-vs-dipeptidyl-peptidase-4-in-peer-reviewed-fulltext-article-JAA